Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria

Jiuyang Zhang, Yung Pin Chen, Kristen P. Miller, Mitra S. Ganewatta, Marpe Bam, Yi Yan, Mitzi Nagarkatti, Alan W. Decho, Chuanbing Tang

Research output: Contribution to journalArticlepeer-review

139 Scopus citations

Abstract

Bacteria are now becoming more resistant to most conventional antibiotics. Methicillin-resistant Staphylococcus aureus (MRSA), a complex of multidrug-resistant Gram-positive bacterial strains, has proven especially problematic in both hospital and community settings by deactivating conventional β-lactam antibiotics, including penicillins, cephalosporins, and carbapenems, through various mechanisms, resulting in increased mortality rates and hospitalization costs. Here we introduce a class of charged metallopolymers that exhibit synergistic effects against MRSA by efficiently inhibiting activity of β-lactamase and effectively lysing bacterial cells. Various conventional β-lactam antibiotics, including penicillin-G, amoxicillin, ampicillin, and cefazolin, are protected from β-lactamase hydrolysis via the formation of unique ion-pairs between their carboxylate anions and cationic cobaltocenium moieties. These discoveries could provide a new pathway for designing macromolecular scaffolds to regenerate vitality of conventional antibiotics to kill multidrug-resistant bacteria and superbugs.

Original languageEnglish (US)
Pages (from-to)4873-4876
Number of pages4
JournalJournal of the American Chemical Society
Volume136
Issue number13
DOIs
StatePublished - Apr 2 2014

Fingerprint Dive into the research topics of 'Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria'. Together they form a unique fingerprint.

Cite this